A comparison of nine scales to detect depression in Parkinson disease: which scale to use?
- PMID: 22422897
- PMCID: PMC3310315
- DOI: 10.1212/WNL.0b013e31824d587f
A comparison of nine scales to detect depression in Parkinson disease: which scale to use?
Abstract
Objective: The Methods of Optimal Depression Detection in Parkinson's Disease (MOOD-PD) study compared the psychometric properties of 9 depression scales to provide guidance on scale selection in Parkinson disease (PD).
Methods: Patients with PD (n = 229) from community-based neurology practices completed 6 self-report scales (Beck Depression Inventory [BDI]-II, Center for Epidemiologic Studies Depression Rating Scale-Revised [CESD-R], 30-item Geriatric Depression Scale [GDS-30], Inventory of Depressive Symptoms-Patient [IDS-SR], Patient Health Questionnaire-9 [PHQ-9], and Unified Parkinson's Disease Rating Scale [UPDRS]-Part I) and were administered 3 clinician-rated scales (17-item Hamilton Depression Rating Scale [HAM-D-17], Inventory of Depressive Symptoms-Clinician [IDS-C], and Montgomery-Åsberg Depression Rating Scale [MADRS] and a psychiatric interview. DSM-IV-TR diagnoses were established by an expert panel blinded to the self-reported rating scale data. Receiver operating characteristic curves were used to estimate the area under the curve (AUC) of each scale.
Results: All scales performed better than chance (AUC 0.75-0.85). Sensitivity ranged from 0.66 to 0.85 and specificity ranged from 0.60 to 0.88. The UPDRS Depression item had a smaller AUC than the BDI-II, HAM-D-17, IDS-C, and MADRS. The CESD-R also had a smaller AUC than the MADRS. The remaining AUCs were statistically similar.
Conclusions: The GDS-30 may be the most efficient depression screening scale to use in PD because of its brevity, favorable psychometric properties, and lack of copyright protection. However, all scales studied, except for the UPDRS Depression, are valid screening tools when PD-specific cutoff scores are used.
Figures


Similar articles
-
Depression rating scales in Parkinson's disease: critique and recommendations.Mov Disord. 2007 Jun 15;22(8):1077-92. doi: 10.1002/mds.21333. Mov Disord. 2007. PMID: 17394234 Free PMC article.
-
Depression rating scales in Parkinson's disease: A critical review updating recent literature.J Affect Disord. 2015 Sep 15;184:216-24. doi: 10.1016/j.jad.2015.05.059. Epub 2015 Jun 10. J Affect Disord. 2015. PMID: 26114228 Review.
-
Perceived Treatment Status of Fluctuations in Parkinson Disease Impacts Suicidality.Am J Geriatr Psychiatry. 2018 Jun;26(6):700-710. doi: 10.1016/j.jagp.2018.01.005. Epub 2018 Jan 31. Am J Geriatr Psychiatry. 2018. PMID: 29609901 Free PMC article.
-
What is the best screening test for depression in chronic spinal pain patients?Spine J. 2014 Jul 1;14(7):1175-82. doi: 10.1016/j.spinee.2013.10.037. Epub 2013 Nov 10. Spine J. 2014. PMID: 24225008
-
Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9).Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S454-66. doi: 10.1002/acr.20556. Arthritis Care Res (Hoboken). 2011. PMID: 22588766 Review. No abstract available.
Cited by
-
Improving Parkinson's Disease Care through Systematic Screening for Depression.Mov Disord Clin Pract. 2024 Oct;11(10):1212-1222. doi: 10.1002/mdc3.14163. Epub 2024 Jul 19. Mov Disord Clin Pract. 2024. PMID: 39030949 Free PMC article.
-
Prevalence, Severity, and Predictors of Poststroke Depression in a Prospective Cohort of Jordanian Patients.Stroke Res Treat. 2022 Jan 7;2022:6506326. doi: 10.1155/2022/6506326. eCollection 2022. Stroke Res Treat. 2022. PMID: 35035872 Free PMC article.
-
A systematic review of depression psychotherapies among Latinos.Clin Psychol Rev. 2016 Apr;45:193-209. doi: 10.1016/j.cpr.2016.04.001. Epub 2016 Apr 9. Clin Psychol Rev. 2016. PMID: 27113679 Free PMC article.
-
Parkinson disease: Scales to detect depression in Parkinson disease.Nat Rev Neurol. 2012 May 15;8(7):359-60. doi: 10.1038/nrneurol.2012.96. Nat Rev Neurol. 2012. PMID: 22584157 No abstract available.
-
Motor Sequence Learning and Consolidation in Unilateral De Novo Patients with Parkinson's Disease.PLoS One. 2015 Jul 29;10(7):e0134291. doi: 10.1371/journal.pone.0134291. eCollection 2015. PLoS One. 2015. PMID: 26222151 Free PMC article.
References
-
- Slaughter JR, Slaughter KA, Nichols D, Holmes SE, Martens MP. Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001; 13: 187– 196 - PubMed
-
- Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2002; 8: 193– 197 - PubMed
-
- O'Connor EA, Whitlock EP, Beil TL, Gaynes BN. Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann Intern Med 2009; 151: 793– 803 - PubMed
-
- Marsh L, McDonald WM, Cummings J, Ravina B. Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group. Mov Disord 2006; 21: 148– 158 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials